Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2022	$ 9,956	$ 145,550,491	$ (101,558,417)	$ 44,002,030
Balance (in shares) at Dec. 31, 2022	30,170,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,080,319	0	2,080,319
Issuances of common stock from the Sales Agreement, net	$ 183	4,588,339	0	4,588,522
Issuances of common stock from the Sales Agreement, net (in shares)	553,293
Net loss	$ 0	0	(9,659,918)	(9,659,918)
Balance at Mar. 31, 2023	$ 10,139	152,219,149	(111,218,335)	41,010,953
Balance (in shares) at Mar. 31, 2023	30,723,610
Balance at Dec. 31, 2022	$ 9,956	145,550,491	(101,558,417)	44,002,030
Balance (in shares) at Dec. 31, 2022	30,170,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(21,194,813)
Balance at Jun. 30, 2023	$ 10,188	155,187,231	(122,753,230)	32,444,189
Balance (in shares) at Jun. 30, 2023	30,868,188
Balance at Dec. 31, 2022	$ 9,956	145,550,491	(101,558,417)	$ 44,002,030
Balance (in shares) at Dec. 31, 2022	30,170,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances of common stock from the Sales Agreement, net (in shares)				2,642,269
Balance at Dec. 31, 2023	$ 10,921	170,620,641	(144,500,615)	$ 26,130,947
Balance (in shares) at Dec. 31, 2023	33,094,521
Balance at Mar. 31, 2023	$ 10,139	152,219,149	(111,218,335)	41,010,953
Balance (in shares) at Mar. 31, 2023	30,723,610
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,105,538	0	2,105,538
Issuances of common stock, from exercise of stock options	$ 1	8,848	0	8,849
Issuances of common stock, from exercise of stock options (in shares)	1,409
Issuance of common stock for consulting agreement	$ 33	609,967	0	610,000
Issuance of common stock for consulting agreement (in shares)	100,000
Issuances of common stock from the Sales Agreement, net	$ 14	243,729	0	243,743
Issuances of common stock from the Sales Agreement, net (in shares)	43,169
Net loss	$ 0	0	(11,534,895)	(11,534,895)
Balance at Jun. 30, 2023	$ 10,188	155,187,231	(122,753,230)	32,444,189
Balance (in shares) at Jun. 30, 2023	30,868,188
Balance at Dec. 31, 2023	$ 10,921	170,620,641	(144,500,615)	26,130,947
Balance (in shares) at Dec. 31, 2023	33,094,521
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,630,011	0	1,630,011
Issuances of common stock, from exercise of stock options	$ 52	531,039	0	531,091
Issuances of common stock, from exercise of stock options (in shares)	156,073
Issuances of common stock from the Sales Agreement, net	$ 1,131	19,493,342	0	19,494,473
Issuances of common stock from the Sales Agreement, net (in shares)	3,428,681
Net loss	$ 0	0	(10,603,477)	(10,603,477)
Balance at Mar. 31, 2024	$ 12,104	192,275,033	(155,104,092)	37,183,045
Balance (in shares) at Mar. 31, 2024	36,679,275
Balance at Dec. 31, 2023	$ 10,921	170,620,641	(144,500,615)	$ 26,130,947
Balance (in shares) at Dec. 31, 2023	33,094,521
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances of common stock from the Sales Agreement, net (in shares)				3,428,681
Net loss				$ (18,931,374)
Balance at Jun. 30, 2024	$ 12,137	194,337,722	(163,431,989)	30,917,870
Balance (in shares) at Jun. 30, 2024	36,779,275
Balance at Mar. 31, 2024	$ 12,104	192,275,033	(155,104,092)	37,183,045
Balance (in shares) at Mar. 31, 2024	36,679,275
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	1,795,722	0	1,795,722
Issuance of common stock for consulting agreement	$ 33	266,967	0	$ 267,000
Issuance of common stock for consulting agreement (in shares)	100,000
Issuances of common stock from the Sales Agreement, net (in shares)				0
Net loss	$ 0	0	(8,327,897)	$ (8,327,897)
Balance at Jun. 30, 2024	$ 12,137	$ 194,337,722	$ (163,431,989)	$ 30,917,870
Balance (in shares) at Jun. 30, 2024	36,779,275